Insider Trading July 2, 2026 09:25 PM

CoreWeave Insider Activity: CSO Brian Venturo Executes $12.9M Share Sales Amid Market Volatility

Executive stock transactions and shifting analyst outlooks highlight the complex valuation landscape for the AI infrastructure provider.

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
CRWV

CoreWeave, Inc. (CRWV) Chief Strategy Officer Brian Venturo executed a series of share transactions totaling approximately $12.9 million in late June and early July 2026. The moves include direct sales to cover tax liabilities from restricted stock unit settlements and indirect sales through affiliated entities operating under a pre-arranged 10b5-1 trading plan. These transactions occurred against a backdrop of a 15% weekly decline in CoreWeave's stock price, which settled at $81.75, reflecting a market capitalization of $46.75 billion. The activity underscores the intricate balance between executive compensation structures and broader market sentiment for AI infrastructure companies.

CoreWeave Insider Activity: CSO Brian Venturo Executes $12.9M Share Sales Amid Market Volatility
CRWV
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • CoreWeave CSO Brian Venturo executed $12.9M in stock sales through direct transactions and affiliated entities to satisfy tax obligations and operate under a 10b5-1 plan, reflecting ongoing executive compensation dynamics in the AI infrastructure sector.
  • CoreWeave's stock declined 15% over the past week to $81.75, with a market capitalization of $46.75 billion, highlighting sensitivity to market sentiment and competitive pressures in the cloud computing and AI markets.
  • Analyst revisions by Evercore ISI project negative earnings per share for CY26 and CY27, while Rosenblatt maintains a Buy rating with a $250 price target, illustrating divergent valuation perspectives in the tech sector.

CoreWeave, Inc. (CRWV) Chief Strategy Officer Brian Venturo executed a series of share transactions totaling approximately $12.9 million in late June and early July 2026. The moves include direct sales to cover tax liabilities from restricted stock unit settlements and indirect sales through affiliated entities operating under a pre-arranged 10b5-1 trading plan. These transactions occurred against a backdrop of a 15% weekly decline in CoreWeave's stock price, which settled at $81.75, reflecting a market capitalization of $46.75 billion. The activity underscores the intricate balance between executive compensation structures and broader market sentiment for AI infrastructure companies.

On June 30, 2026, Venturo directly sold 65,493 shares of CoreWeave's Class A Common Stock at a price of $95.69 per share. These specific shares were liquidated to satisfy tax withholding obligations triggered by the vesting and settlement of restricted stock units. Simultaneously on June 30, Venturo acquired 126,771 shares of Class A Common Stock through the settlement of these restricted stock units. Each restricted stock unit represents a contingent right to receive one share of CoreWeave's Class A Common Stock upon vesting.

Transactions continued on July 1, 2026, through entities associated with Venturo. West Clay Capital LLC, for which Venturo serves as the managing member, sold 61,532 shares of Class A Common Stock. These sales were executed in multiple transactions with weighted average prices ranging from $85.6261 to $90.16. Concurrently, the Venturo Family GST Exempt Trust sold 15,380 shares of Class A Common Stock. The trust is structured with Venturo's spouse as trustee and minor children as beneficiaries. Both entities acquired their respective Class A shares on July 1 through the conversion of Class B Common Stock, which is convertible into Class A Common Stock at the holder's election.

Following these transactions, Venturo directly holds 235,883 shares of Class A Common Stock and 1,285,064 Restricted Stock Units. His indirect holdings are extensive. Through his father-in-law, 22,500 shares are held, though Venturo disclaims beneficial ownership except for any pecuniary interest. The YOLO APV Trust holds 82,679 shares, and the YOLO ECV Trust holds 82,687 shares. Indirectly, Venturo holds 2,001,900 shares of Class B Common Stock through his spouse. He also holds 1,788,596 shares of Class B Common Stock through the Venturo Family 2024 Friends and Family GRAT, where he acts as the sole trustee and beneficiary. Additionally, 5,402,057 shares of Class B Common Stock are held through the Venturo Family Trust. Venturo directly holds an additional 5,343,347 shares of Class B Common Stock.

CoreWeave has recently launched ARIA, an AI research agent designed to analyze experiment data within Weights & Biases, supporting model and agent development. This launch coincided with the general availability of W&B Weave, CoreWeave's agent development platform. The company's stock ratings have been reiterated by analysts amid reports about Meta Platforms' plans for a cloud infrastructure business. Rosenblatt maintained a Buy rating with a price target of $250. Evercore ISI reiterated an Outperform rating with a $150 price target and updated its financial model. The updated estimates show a projected negative earnings per share for CY26 and CY27. These developments occur as Meta Platforms considers selling access to AI computing power and raw computing capacity, which could impact CoreWeave's market position.

Risks

  • CoreWeave faces potential market position impacts as Meta Platforms considers selling access to AI computing power and raw computing capacity, which could intensify competition in the cloud infrastructure market.
  • Evercore ISI's updated financial model projects negative earnings per share for CY26 and CY27, indicating potential profitability challenges and valuation risks in the AI infrastructure sector.
  • The 15% weekly decline in CoreWeave's stock to $81.75 reflects broader market volatility and sensitivity to competitive dynamics in the technology and AI markets.

More from Insider Trading

Spyre Therapeutics CFO Executes Pre-Arranged Share Sales Amid Clinical Momentum Jul 2, 2026 Lightspeed Affiliates Divest $260K in Navan Shares Amid Post-IPO Restructuring Jul 2, 2026 Lightspeed Management Exits Navan Position; Company Pursues Strategic Acquisitions and AI Integrations Jul 2, 2026 Spyre Therapeutics CMO Sheldon Sloan Liquidates Holdings Following $730K Sale Jul 2, 2026 Spyre Therapeutics CEO Cameron Turtle Sells $1.32M in Shares Amid Pipeline Progress Jul 2, 2026